- Home
- MDXG vs CINT Comparison
MDXG vs CINT Comparison
Compare MDXG & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- CINT
- Stock Information
- Founded
- MDXG 2006
- CINT 1995
- Country
- MDXG United States
- CINT Brazil
- Employees
- MDXG N/A
- CINT N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- CINT EDP Services
- Sector
- MDXG Health Care
- CINT Technology
- Exchange
- MDXG Nasdaq
- CINT Nasdaq
- Market Cap
- MDXG 1.1B
- CINT 906.5M
- IPO Year
- MDXG N/A
- CINT 2021
- Fundamental
- Price
- MDXG $9.10
- CINT $6.22
- Analyst Decision
- MDXG Strong Buy
- CINT Buy
- Analyst Count
- MDXG 5
- CINT 7
- Target Price
- MDXG $12.00
- CINT $7.40
- AVG Volume (30 Days)
- MDXG 814.8K
- CINT 72.1K
- Earning Date
- MDXG 10-30-2024
- CINT 11-14-2024
- Dividend Yield
- MDXG N/A
- CINT N/A
- EPS Growth
- MDXG N/A
- CINT 15.05
- EPS
- MDXG 0.52
- CINT 0.16
- Revenue
- MDXG $342,804,000.00
- CINT $410,247,558.00
- Revenue This Year
- MDXG $9.56
- CINT $6.56
- Revenue Next Year
- MDXG $9.19
- CINT $15.42
- P/E Ratio
- MDXG $18.08
- CINT $37.95
- Revenue Growth
- MDXG 10.93
- CINT N/A
- 52 Week Low
- MDXG $5.47
- CINT $3.34
- 52 Week High
- MDXG $10.14
- CINT $8.04
- Technical
- Relative Strength Index (RSI)
- MDXG 53.38
- CINT 42.14
- Support Level
- MDXG $9.07
- CINT $5.74
- Resistance Level
- MDXG $9.60
- CINT $7.20
- Average True Range (ATR)
- MDXG 0.32
- CINT 0.27
- MACD
- MDXG -0.16
- CINT -0.06
- Stochastic Oscillator
- MDXG 14.05
- CINT 32.88
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About CINT CI&T Inc
CI&T Inc is engaged in providing strategy, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.